Cargando…
Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment
INTRODUCTION: Secondary tumoral parkinsonism is a rare phenomenon that develops as a direct or indirect result of brain neoplasms or related conditions. OBJECTIVES: The first objective was to explore to what extent brain neoplasms, cavernomas, cysts, paraneoplastic syndromes (PNSs), and oncological...
Autores principales: | Cedergren Weber, Gustav, Timpka, Jonathan, Rydelius, Anna, Bengzon, Johan, Odin, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454247/ https://www.ncbi.nlm.nih.gov/pubmed/37433071 http://dx.doi.org/10.1002/brb3.3151 |
Ejemplares similares
-
Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease
por: van Wamelen, Daniel J., et al.
Publicado: (2018) -
Time to workforce exit after a Parkinson’s disease diagnosis
por: Timpka, Jonathan, et al.
Publicado: (2023) -
Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future
por: Ray Chaudhuri, K, et al.
Publicado: (2016) -
Close relationships in Parkinson´s disease patients with device‐aided therapy
por: Scharfenort, Monica, et al.
Publicado: (2021) -
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
por: Timpka, Jonathan, et al.
Publicado: (2018)